Related Experiment Videos
Tranexamic acid in primary CABG surgery: high vs low dose.
G Armellin1, A Vinciguerra, R Bonato
1Department of Pharmacology and Anesthesiology Egidio Meneghetti, University of Padua, Padua, Italy. gabriarmellin@libero.it
Minerva Anestesiologica
|March 5, 2004
Summary
Both high and low doses of tranexamic acid are equally effective in reducing bleeding and transfusions during coronary artery bypass surgery. Optimal timing for administration remains a consideration for maximizing benefits.
Area of Science:
- Cardiovascular Surgery
- Anesthesiology
- Pharmacology
Background:
- Prophylactic tranexamic acid use is established for reducing bleeding and transfusions in cardiac procedures.
- Optimal dosing and timing for tranexamic acid administration in cardiac surgery remain incompletely defined.
Purpose of the Study:
- To compare the efficacy of two different prophylactic tranexamic acid regimens in patients undergoing elective coronary revascularization.
- To determine if dose or timing influences transfusion requirements and blood loss.
Main Methods:
- A randomized trial involving 250 patients undergoing elective primary coronary revascularization.
- Group H received 60 mg/kg tranexamic acid (30 mg/kg pre-CPB, 30 mg/kg in CPB prime).
- Group L received a weight-based dose followed by an infusion (15 mg/kg bolus + 1 mg/kg/hr infusion).
Main Results:
- No significant differences in transfusion requirements were observed between Group H and Group L.
- No significant differences in postoperative blood loss were found between the two treatment groups.
- Coagulation profiles were also comparable between groups.
Conclusions:
- Both evaluated prophylactic tranexamic acid regimens demonstrate equal efficacy in elective primary coronary artery bypass surgery.
- Administering tranexamic acid during full heparinization may offer theoretical safety advantages regarding thrombus formation.